Association between initial fluid choice and subsequent in-hospital mortality during the resuscitation of adults with septic shock

Anesthesiology

Volumn 123, Issue 6, 2015, Pages 1385-1393

  Raghunathan, Karthik ^a,b   Bonavia, Anthony ^c   Nathanson, Brian H ^d   Beadles, Christopher A ^e   Shaw, Andrew D ^f   Brookhart, M Alan ^g   Miller, Timothy E ^a   Lindenauer, Peter K ^h  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d OptiStatim   (United States)

^e RTI INTERNATIONAL   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^g IL   (United States)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BICARBONATE; DIURETIC AGENT; HYDROCORTISONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; ISOTONIC SOLUTION; STEROID; CRYSTALLOID; SODIUM CHLORIDE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COLLOID; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTALLOID; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FLUID RESUSCITATION; HEALTH CARE COST; HUMAN; HYPERTENSION; ICD-9-CM; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPENSITY SCORE; RESUSCITATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPTIC SHOCK; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; FLUID THERAPY; HOSPITAL MORTALITY; MIDDLE AGED; PROCEDURES; SHOCK, SEPTIC; STATISTICS AND NUMERICAL DATA;

AGED; COHORT STUDIES; FEMALE; FLUID THERAPY; HOSPITAL MORTALITY; HUMANS; ISOTONIC SOLUTIONS; LENGTH OF STAY; MALE; MIDDLE AGED; PROPENSITY SCORE; RESUSCITATION; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SODIUM CHLORIDE; TREATMENT OUTCOME;

EID: 84947493206     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000861     Document Type: Article

References (35)

1. Mayr FB, Yende S, Angus DC, Epidemiology of severe sepsis. Virulence 2014 5 4 11
2. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK, Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012 40 754 61
3. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003 31 1250 6
4. Myburgh JA, Mythen MG, Resuscitation fluids. N Engl J Med 2013 369 1243 51
5. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013 39 165 228
6. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008 358 125 39
7. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J, 6S Trial Group; Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012 367 124 34
8. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014 370 1412 21
9. Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J, Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis. BMJ 2013 346 f839
10. Bansal M, Farrugia A, Balboni S, Martin G, Relative survival benefit and morbidity with fluids in severe sepsis-A network meta-analysis of alternative therapies. Curr Drug Saf 2013 8 236 45
11. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA, CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012 367 1901 11
12. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004 350 2247 56
13. McIntyre LA, Fergusson D, Cook DJ, Rankin N, Dhingra V, Granton J, Magder S, Stiell I, Taljaard M, Hebert PC, Canadian Critical Care Trials Group Fluid resuscitation in the management of early septic shock (FINESS): A randomized controlled feasibility trial. Can J Anaesth 2008 55 819 26
14. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H, Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012 16 R94
15. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM, FEAST Trial Group Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011 364 2483 95
16. Raghunathan K, Shaw A, Nathanson B, Stürmer T, Brookhart A, Stefan MS, Setoguchi S, Beadles C, Lindenauer PK, Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis∗. Crit Care Med 2014 42 1585 91
17. Raghunathan K, Beadles C, Nathanson BH, Lindenauer PK, The authors reply. Crit Care Med 2015 43 e27 8
18. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA, Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012 255 821 9
19. Burdett E, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MP, James MF, Mythen MG, O'Malley CM, Roche AM, Rowan K, Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev 2012 12 CD004089
20. Martin GS, Mannino DM, Eaton S, Moss M, The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003 348 1546 54
21. Lin DY, Psaty BM, Kronmal RA, Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998 54 948 63
22. Sjoding MW, Luo K, Miller MA, Iwashyna TJ, When do confounding by indication and inadequate risk adjustment bias critical care studies? A simulation study. Crit Care 2015 19 195
23. Wilcox CS, Regulation of renal blood flow by plasma chloride. J Clin Invest 1983 71 726 35
24. Bullivant EM, Wilcox CS, Welch WJ, Intrarenal vasoconstriction during hyperchloremia: Role of thromboxane. Am J Physiol 1989 256 (1 pt 2) F152 7
25. Chowdhury AH, Cox EF, Francis ST, Lobo DN, A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline (Voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2013 259 881 7
26. Lobo DN, Stanga Z, Aloysius MM, Wicks C, Nunes QM, Ingram KL, Risch L, Allison SP, Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010 38 464 70
27. McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS, Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: A propensity-matched cohort study. Anesth Analg 2013 117 412 21
28. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M, Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012 308 1566 72
29. O'Malley CM, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS, Bennett-Guerrero E, A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005 100 1518 24
30. Todd SR, Malinoski D, Muller PJ, Schreiber MA, Lactated Ringer's is superior to normal saline in the resuscitation of uncontrolled hemorrhagic shock. J Trauma 2007 62 636 9
31. Young JB, Utter GH, Schermer CR, Galante JM, Phan HH, Yang Y, Anderson BA, Scherer LA, Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: A randomized trial. Ann Surg 2014 259 255 62
32. Prough DS, Bidani A, Hyperchloremic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. A nesthesiology 1999 90 1247 9
33. Scheingraber S, Rehm M, Sehmisch C, Finsterer U, Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. A nesthesiology 1999 90 1265 70
34. Lee J, Iqbal S, Gursahaney A, Nouh T, Khwaja K, Medicine versus surgery/anesthesiology intensivists: A retrospective review and comparison of outcomes in a mixed medical-surgical-trauma ICU. Can J Surg 2013 56 275 9
35. Chung KK, Dubick MA, Building the case toward a definitive clinical trial: Saline versus Plasma-Lyte∗. Crit Care Med 2014 42 1009 10